MedPath
FDA Approval

Methenamine Hippurate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
March 24, 2014
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Carilion Materials Management

079239644

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Carilion Materials Management

Carilion Materials Management

Carilion Materials Management

079239644

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Methenamine Hippurate

Product Details

NDC Product Code
68151-0984
Application Number
ANDA076411
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
June 18, 2014
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
Code: M329791L57Class: ACTIBQuantity: 1 g in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POVIDONE K29/32Inactive
Code: 390RMW2PEQClass: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TYClass: IACT
© Copyright 2025. All Rights Reserved by MedPath